Metabolic dysfunction–associated steatotic liver disease (MASLD) is linked to insulin resistance and cardiometabolic disorders. This review synthesizes current information on the epidemiology, pathophysiology, and treatment of MASLD and its progressive form, metabolic dysfunction– associated steatohepatitis (MASH), und...
Risheng Xu, N. Abate, R. Stribling et al.· Cleveland Clinic journal of...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.